Nitorum Capital, L.P. United Therapeutics Corp Transaction History
Nitorum Capital, L.P.
- $901 Million
- Q3 2024
A detailed history of Nitorum Capital, L.P. transactions in United Therapeutics Corp stock. As of the latest transaction made, Nitorum Capital, L.P. holds 113,328 shares of UTHR stock, worth $40.7 Million. This represents 4.51% of its overall portfolio holdings.
Number of Shares
113,328
Previous 140,822
19.52%
Holding current value
$40.7 Million
Previous $44.9 Million
9.47%
% of portfolio
4.51%
Previous 5.09%
Shares
5 transactions
Others Institutions Holding UTHR
# of Institutions
676Shares Held
42.1MCall Options Held
194KPut Options Held
295K-
Black Rock Inc. New York, NY5.47MShares$1.96 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.41MShares$1.58 Billion0.03% of portfolio
-
Wellington Management Group LLP Boston, MA3.17MShares$1.14 Billion0.2% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.86MShares$1.03 Billion15.42% of portfolio
-
State Street Corp Boston, MA2.24MShares$803 Million0.03% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $16.3B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...